IDEXX Labs (IDXX) Misses Q4 EPS Views; Nudges FY15 Outlook Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/25/2026
- Wall St futures gain as AI enthusiasm eases worries over higher oil prices, yields
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- US and Iran discuss phased deal to reopen Hormuz and end US blockade, sources say
IDEXX Laboratories (IDXX) PT Raised to $160 at Piper Jaffray Following In-Line Q4; 'Neutral' Rating Maintained
February 2, 2015 7:23 AM ESTPiper Jaffray analyst Kevin Ellich raised his price target on IDEXX Laboratories (NASDAQ: IDXX) to $160.00 (from $129.00) following mostly in-line Q4 results. The firm maintained a Neutral rating.
Ellich commented, "Q4 results were relatively in line with Street expectations and IDXX increased FY15 normalized... More
